Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFMG |
Texto Completo: | http://dx.doi.org/10.31744/einstein_journal/2022ao6453 http://hdl.handle.net/1843/60532 https://orcid.org/0000-0003-3083-5431 https://orcid.org/0000-0003-2550-7249 https://orcid.org/0000-0002-5528-0658 https://orcid.org/0000-0003-1465-9167 https://orcid.org/0000-0002-0210-0721 https://orcid.org/0000-0002-5880-5261 https://orcid.org/0000-0003-0138-9401 |
Resumo: | Objective: To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Methods: An open prospective cohort was carried out from 2011 to 2019, in Belo Horizonte (MG). Functionality was assessed using the Health Assessment Questionnaire Disability-Index at baseline, and after 6 and 12 months of follow-up. Factors associated with poor functionality were identified through logistic regression. Results: The median Health Assessment Questionnaire Disability-Index at baseline was 1.5 (interquartile range of 0.8-1.9), with poor functionality observed in patients with rheumatoid arthritis. Improved functionality was seen at 6 months of treatment for the three diseases. The predictors of poor functionality at 6 months for psoriatic arthritis and ankylosing spondylitis were female sex, low education levels, and high disease activity; and for rheumatoid arthritis and psoriatic arthritis were female sex, advanced age, and high disease activity. In 12 months, the three diseases had predictors of worse functionality: female sex, low education, and high disease activity. Conclusion: There was a significant improvement in functionality during the follow-up, with better response at 6 months of treatment. Poor functionality was observed in older, female patients, with low education and high disease activity. |
id |
UFMG_0e82a16e164d09adec8e6e0190508c9c |
---|---|
oai_identifier_str |
oai:repositorio.ufmg.br:1843/60532 |
network_acronym_str |
UFMG |
network_name_str |
Repositório Institucional da UFMG |
repository_id_str |
|
spelling |
2023-11-06T20:49:02Z2023-11-06T20:49:02Z2022202220http://dx.doi.org/10.31744/einstein_journal/2022ao64532317-6385http://hdl.handle.net/1843/60532https://orcid.org/0000-0003-3083-5431https://orcid.org/0000-0003-2550-7249https://orcid.org/0000-0002-5528-0658https://orcid.org/0000-0003-1465-9167https://orcid.org/0000-0002-0210-0721https://orcid.org/0000-0002-5880-5261https://orcid.org/0000-0003-0138-9401Objective: To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Methods: An open prospective cohort was carried out from 2011 to 2019, in Belo Horizonte (MG). Functionality was assessed using the Health Assessment Questionnaire Disability-Index at baseline, and after 6 and 12 months of follow-up. Factors associated with poor functionality were identified through logistic regression. Results: The median Health Assessment Questionnaire Disability-Index at baseline was 1.5 (interquartile range of 0.8-1.9), with poor functionality observed in patients with rheumatoid arthritis. Improved functionality was seen at 6 months of treatment for the three diseases. The predictors of poor functionality at 6 months for psoriatic arthritis and ankylosing spondylitis were female sex, low education levels, and high disease activity; and for rheumatoid arthritis and psoriatic arthritis were female sex, advanced age, and high disease activity. In 12 months, the three diseases had predictors of worse functionality: female sex, low education, and high disease activity. Conclusion: There was a significant improvement in functionality during the follow-up, with better response at 6 months of treatment. Poor functionality was observed in older, female patients, with low education and high disease activity.Objetivo: Avaliar a resposta terapêutica (funcionalidade) e seus fatores associados em pacientes em uso de medicamentos biológicos no Sistema Único de Saúde para tratamento de artrite reumatoide, artrite psoriática e espondilite anquilosante. Métodos: Foi realizada uma coorte prospectiva aberta de 2011 a 2019, em Belo Horizonte (MG). A funcionalidade foi avaliada por meio do Health Assessment Questionnaire Disability-Index no início do estudo e após 6 e 12 meses de acompanhamento. Fatores associados à funcionalidade deficiente foram identificados por meio de regressão logística. Resultados: A mediana do Índice de Incapacidade do Questionário de Avaliação de Saúde no início do estudo foi de 1,5 (intervalo interquartil de 0,8-1,9), com funcionalidade deficiente observada em pacientes com artrite reumatóide. A funcionalidade melhorada foi observada aos 6 meses de tratamento para as três doenças. Os preditores de baixa funcionalidade aos 6 meses para artrite psoriática e espondilite anquilosante foram mulheres sexo, baixos níveis de escolaridade e alta atividade de doenças; e para artrite reumatoide e artrite psoriática foram sexo feminino, idade avançada e alta atividade da doença. Em 12 meses, as três doenças apresentaram preditores de pior funcionalidade: sexo feminino, baixa escolaridade e alta atividade da doença. Conclusão: Houve melhora significativa da funcionalidade durante o acompanhamento, com melhor resposta aos 6 meses de tratamento. A funcionalidade deficiente foi observada em pacientes mais velhos, do sexo feminino, com baixa escolaridade e alta atividade da doença.CNPq - Conselho Nacional de Desenvolvimento Científico e TecnológicoFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas GeraisengUniversidade Federal de Minas GeraisUFMGBrasilFAR - DEPARTAMENTO DE FARMÁCIA SOCIALeinstein (São Paulo)EfetividadeArtrite reumatoideArtrite psoriásicaEspondilite anquilosanteProdutos biológicosSistema Único de SaúdeDoenças reumáticasEffectivenessArthritis, rheumatoidArthritis, psoriaticSpondylitis, ankylosingBiological productsUnified Health SystemRheumatic diseasesFunctionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health SystemAvaliação da funcionalidade em pacientes com doenças reumáticas em tratamento no Sistema Único de Saúdeinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://journal.einstein.br/article/functionality-assessment-in-patients-with-rheumatic-diseases-undergoing-treatment-in-the-public-health-system/Elisa Neide Barbosa de SouzaMichael Ruberson Ribeiro da SilvaJéssica Barreto Ribeiro Dos SantosEdna Afonso ReisJuliana Alvares TeodoroFrancisco de Assis AcurcioAlessandra Maciel Almeidaapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/60532/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALFunctionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System.pdfFunctionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System.pdfapplication/pdf215158https://repositorio.ufmg.br/bitstream/1843/60532/2/Functionality%20assessment%20in%20patients%20with%20rheumatic%20diseases%20undergoing%20treatment%20in%20the%20Public%20Health%20System.pdf58bc9ad9b46c8fe25850ecd46525e6dcMD521843/605322023-11-06 17:49:03.173oai:repositorio.ufmg.br:1843/60532Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-11-06T20:49:03Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
dc.title.pt_BR.fl_str_mv |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
dc.title.alternative.pt_BR.fl_str_mv |
Avaliação da funcionalidade em pacientes com doenças reumáticas em tratamento no Sistema Único de Saúde |
title |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
spellingShingle |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System Elisa Neide Barbosa de Souza Effectiveness Arthritis, rheumatoid Arthritis, psoriatic Spondylitis, ankylosing Biological products Unified Health System Rheumatic diseases Efetividade Artrite reumatoide Artrite psoriásica Espondilite anquilosante Produtos biológicos Sistema Único de Saúde Doenças reumáticas |
title_short |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
title_full |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
title_fullStr |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
title_full_unstemmed |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
title_sort |
Functionality assessment in patients with rheumatic diseases undergoing treatment in the Public Health System |
author |
Elisa Neide Barbosa de Souza |
author_facet |
Elisa Neide Barbosa de Souza Michael Ruberson Ribeiro da Silva Jéssica Barreto Ribeiro Dos Santos Edna Afonso Reis Juliana Alvares Teodoro Francisco de Assis Acurcio Alessandra Maciel Almeida |
author_role |
author |
author2 |
Michael Ruberson Ribeiro da Silva Jéssica Barreto Ribeiro Dos Santos Edna Afonso Reis Juliana Alvares Teodoro Francisco de Assis Acurcio Alessandra Maciel Almeida |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Elisa Neide Barbosa de Souza Michael Ruberson Ribeiro da Silva Jéssica Barreto Ribeiro Dos Santos Edna Afonso Reis Juliana Alvares Teodoro Francisco de Assis Acurcio Alessandra Maciel Almeida |
dc.subject.por.fl_str_mv |
Effectiveness Arthritis, rheumatoid Arthritis, psoriatic Spondylitis, ankylosing Biological products Unified Health System Rheumatic diseases |
topic |
Effectiveness Arthritis, rheumatoid Arthritis, psoriatic Spondylitis, ankylosing Biological products Unified Health System Rheumatic diseases Efetividade Artrite reumatoide Artrite psoriásica Espondilite anquilosante Produtos biológicos Sistema Único de Saúde Doenças reumáticas |
dc.subject.other.pt_BR.fl_str_mv |
Efetividade Artrite reumatoide Artrite psoriásica Espondilite anquilosante Produtos biológicos Sistema Único de Saúde Doenças reumáticas |
description |
Objective: To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Methods: An open prospective cohort was carried out from 2011 to 2019, in Belo Horizonte (MG). Functionality was assessed using the Health Assessment Questionnaire Disability-Index at baseline, and after 6 and 12 months of follow-up. Factors associated with poor functionality were identified through logistic regression. Results: The median Health Assessment Questionnaire Disability-Index at baseline was 1.5 (interquartile range of 0.8-1.9), with poor functionality observed in patients with rheumatoid arthritis. Improved functionality was seen at 6 months of treatment for the three diseases. The predictors of poor functionality at 6 months for psoriatic arthritis and ankylosing spondylitis were female sex, low education levels, and high disease activity; and for rheumatoid arthritis and psoriatic arthritis were female sex, advanced age, and high disease activity. In 12 months, the three diseases had predictors of worse functionality: female sex, low education, and high disease activity. Conclusion: There was a significant improvement in functionality during the follow-up, with better response at 6 months of treatment. Poor functionality was observed in older, female patients, with low education and high disease activity. |
publishDate |
2022 |
dc.date.issued.fl_str_mv |
2022 |
dc.date.accessioned.fl_str_mv |
2023-11-06T20:49:02Z |
dc.date.available.fl_str_mv |
2023-11-06T20:49:02Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1843/60532 |
dc.identifier.doi.pt_BR.fl_str_mv |
http://dx.doi.org/10.31744/einstein_journal/2022ao6453 |
dc.identifier.issn.pt_BR.fl_str_mv |
2317-6385 |
dc.identifier.orcid.pt_BR.fl_str_mv |
https://orcid.org/0000-0003-3083-5431 https://orcid.org/0000-0003-2550-7249 https://orcid.org/0000-0002-5528-0658 https://orcid.org/0000-0003-1465-9167 https://orcid.org/0000-0002-0210-0721 https://orcid.org/0000-0002-5880-5261 https://orcid.org/0000-0003-0138-9401 |
url |
http://dx.doi.org/10.31744/einstein_journal/2022ao6453 http://hdl.handle.net/1843/60532 https://orcid.org/0000-0003-3083-5431 https://orcid.org/0000-0003-2550-7249 https://orcid.org/0000-0002-5528-0658 https://orcid.org/0000-0003-1465-9167 https://orcid.org/0000-0002-0210-0721 https://orcid.org/0000-0002-5880-5261 https://orcid.org/0000-0003-0138-9401 |
identifier_str_mv |
2317-6385 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
einstein (São Paulo) |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.publisher.initials.fl_str_mv |
UFMG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
FAR - DEPARTAMENTO DE FARMÁCIA SOCIAL |
publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
instname_str |
Universidade Federal de Minas Gerais (UFMG) |
instacron_str |
UFMG |
institution |
UFMG |
reponame_str |
Repositório Institucional da UFMG |
collection |
Repositório Institucional da UFMG |
bitstream.url.fl_str_mv |
https://repositorio.ufmg.br/bitstream/1843/60532/1/License.txt https://repositorio.ufmg.br/bitstream/1843/60532/2/Functionality%20assessment%20in%20patients%20with%20rheumatic%20diseases%20undergoing%20treatment%20in%20the%20Public%20Health%20System.pdf |
bitstream.checksum.fl_str_mv |
fa505098d172de0bc8864fc1287ffe22 58bc9ad9b46c8fe25850ecd46525e6dc |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
repository.mail.fl_str_mv |
|
_version_ |
1803589232759930880 |